ClinicalTrials.gg
CompletedNCT03777397DEPSEIN_HCLUpdated Sep 20, 2019

Awareness About Breast Cancer Screening

An observational study in Breast Cancer, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to female participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-20.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
2,264
Ages
18 Years to 70 Years
Sex
Female
01

Study summary

Breast cancer is the most common cancer in French women, with 52000 new cases each year.

Shift work and night work is recognized by International Agency for Research on Cancer as a potential risk factor. Epidemiological studies find, for most of them, an increased risk of breast cancer compared with general population. Physiological hypothesis rely on the melatonin role in defense against tumorigenesis.

According to High Authority of Health clinical good practice guidelines, the risk does not justify more screening than the organized screening. We do not have information about awareness level of workers in health structures, specially in the Hospices Civils de Lyon.

Investigators would like to know how employees take part to breast cancer screening, specially in night workers.

This study, as a survey, is a first step to evaluate the need for specific actions to increase the participation to breast cancer screening.

02

Conditions studied

  • Breast Cancer

Browse trials for

03

In context

Breast Neoplasms

12,820 studies on the registry are indexed under Breast Neoplasms; 2,920 are open to participants now.

This study's enrollment of 2,264 is above the median of 184 across 2,711 observational studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,856 studies on the registry; 442 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women employees of Hospices Civils de Lyon

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • employees HCL
  • women

Exclusion criteria

Exclusion Criteria:

  • \<18 years old
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
2,264 participants (actual)
Patient registry
No

Interventions

  • OtherQuestionnaire

    Questionnaire on the level of awareness of this risk among health sector employees, and more specifically the Lyon Civilian Hospices, and on participation in breast cancer screening for HCL employees, particularly among night shift staff.

06

What researchers measure

Primary outcomes

  1. Participation of HCL female staff in mammography screening for breast cancer

    One question of the questionnaire is about this participation

    Time frame: 5 minutes

07

Study locations

1 site
  • Service de Gynécologie - Hôpital de la Croix-Rousse - Hospices Civils de Lyon
    Lyon, 69004, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 20, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03777397
Responsible party
Sponsor
First posted
Dec 17, 2018
Start date
Jan 24, 2019
Primary completion
Feb 7, 2019
Completion
Feb 7, 2019
Last update
Sep 20, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion